United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

Following a two year investigation, the UK's Competition and Markets Authority ("CMA") has issued its provisional findings in which it proposes to impose significant obligations on veterinary business.

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes - particularly when the underlying science defies straightforward explanation.

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

The life sciences industry (which for the purposes of this article are seen as encompassing medicine, biotechnology and pharmaceuticals)...

United Kingdom Healthcare

BJ

Browne Jacobson

MHRA And NICE Launch Aligned Approvals Pathway

On 10 October 2025, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence...

United Kingdom Healthcare

AP

Arnold & Porter

Biopharma M&A Activity – Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Venture Investment In Life Sciences – Activity Update & Outlook (US & Europe)

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

EU Data Act: Is Your Business Ready?

European Union Privacy

AG

Addleshaw Goddard

AI In Medical Devices: Patent Eligibility

United Kingdom IP

MC

Marks & Clerk

Article 22 Trends In Pharma M&A: Call-In Powers And Timing

United Kingdom Healthcare

AP

Arnold & Porter

Interview With Citrine Informatics: AI, Data, And The Future Of Materials Science

United Kingdom Technology

KL

Keltie LLP

A Milestone For Precision Breeding But Will The UK-EU Reset Pause Progress?

European Union Healthcare

M

Murgitroyd

Biopharma M&A Activity – As We Enter The Latter Months Of 2025, Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

United Kingdom Healthcare

AO

A&O Shearman

UK Immigration Update – Indefinite Leave To Remain ILR After 10 Years Residence

United Kingdom Immigration

TL

Thaxted Legal

The Use Of AI By Arbitrators: Exploring The Opportunities And Managing The Risks

United Kingdom Technology

AG

Addleshaw Goddard

Shaping The Future Of Build To Rent: Quintain Living At Wembley Park (Podcast)

United Kingdom Real Estate

GW

Gowling WLG

Travers Smith's Sustainability Insights: Why Less Might Be More (Podcast)

United Kingdom Commercial

TS

Travers Smith LLP

UK Government Unveils Ambitious Compute Roadmap To Bolster AI And National Infrastructure

United Kingdom Technology

BB

Baker Botts LLP

Immigration And The UK's Industrial Vision

In today's global economy, competition to attract the most desirable talent is fierce with many countries seeking to improve their attractiveness.

United Kingdom Immigration

LS

Lewis Silkin

AI In The Healthcare Sphere: Public And Private Considerations

Healthcare and legal professionals dealing with medical negligence need to be aware of these issues as they navigate claims involving AI.

United Kingdom Technology

BJ

Browne Jacobson

European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance

On August 21, 2025, Alvotech and Advanz Pharma Holdco Limited ("Advanz") announced that MYNZEPLI®, a biosimilar of Regeneron's EYLEA® (aflibercept), was approved by the European Commission.

European Union Healthcare

GP

Goodwin Procter LLP

Hot Topics: Life Sciences

Topics in this month's update include: a decline in the number of "megatenants" in the US life sciences sector; the MHRA being designated as a WHO-Listed Authority; and a surge in Chinese biotech share values.

United Kingdom Healthcare

AG

Addleshaw Goddard

Neurotech Patents In Europe: Methods, Medical Devices, And The EPC Exclusion

United Kingdom IP

MC

Marks & Clerk

The Thursday Investment Club: The Case For Later Living

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

United Kingdom Healthcare

AP

Arnold & Porter

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

On August 1, 2025, a UK Court of Appeal upheld the validity of Moderna's European Patent No. 3,590,949 ("EP'949") in a dispute with Pfizer and BioNTech.

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

Earlier this year, the European Commission launched a Biotech and Biomanufacturing Hub that provides tools and resources to help companies, particularly start-ups and SMEs...

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

Covert medication means giving someone medicine without their knowledge or consent, usually by disguising it in food or drink, or by administering it through a tube.

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

The UK government has published its response to the recent consultation on the UK Medical Devices Regulations.

United Kingdom Healthcare

AP

Arnold & Porter

UK Proposes Early Access Service For Innovative Medical Devices

United Kingdom Healthcare

AP

Arnold & Porter

Virtual And Digital Health Digest – July 2025

This digest covers key virtual and digital health regulatory and public policy developments during June and early July 2025 from the United Kingdom and European Union.

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

In the UK's Industrial Strategy, life sciences is one of eight high-growth sectors (the IS-8) with the potential to drive economic growth – while also supporting economic security and resilience...

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

The UK Government has recently published plans for the Life Sciences Sector and the NHS in England. In this blog post, we summarise these plans and some of the initial feedback that has been published by ABPI.

United Kingdom Healthcare

AP

Arnold & Porter

Life Science Sector Plans Issued

We've recently written about the UK's industrial strategy and its specific plans for the tech and creative sectors. It has now published its life sciences sector plan - and so has the EU...

United Kingdom Healthcare

LS

Lewis Silkin

A New European Strategy To Foster Life Sciences Innovation And Market Access

European Union Healthcare

AO

A&O Shearman

Tackling The Source Of Phantom Limb Pain With Nerve Stimulation

United Kingdom IP

MC

Marks & Clerk

The Case For Core Focus Among Mid-market Medical Device Companies

United Kingdom Healthcare

A

AlixPartners

Neurotech Patents In Europe: Part 2 - Novelty, Inventive Step, And Device-Specific Pitfalls

United Kingdom IP

MC

Marks & Clerk

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

Worldwide Healthcare

PC

Potter Clarkson

The Pioneers: Financial Times Interview With Michelle Mitchell

United Kingdom Healthcare

WL

Withers LLP

Supporting Growth – What Does The UK's Industrial Strategy Mean For Life Sciences?

United Kingdom Healthcare

GW

Gowling WLG

UK Government Issues New Industrial Strategy

United Kingdom Strategy

LS

Lewis Silkin

EU Medical Device Software: New Guidance On Placing Software Medical Devices On The EU Market

European Union Healthcare

AP

Arnold & Porter

Personalised Medicine And MedTech

United Kingdom Healthcare

LS

Lewis Silkin

UPC Delivers First Judgment On Validity And Infringement Of A Second Medical Use Claim

United Kingdom IP

HL

HGF Ltd

Looking To The Future - UK Biotech In 2035

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

European Union Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Resolving UK/EU Regulatory Disputes (Video)

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Webinar: Supplementary Protection Certificates - Part Two (Video)

D

Dehns

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Measuring The Return From Pharmaceutical Innovation 2012 (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More